IP Library Granted Patent US 6,929,633
Granted Patent B2
US 6,929,633 · App. 10/278,735 · Granted Aug 16, 2005

Apparatus and methods for clot dissolution

Assignee: Bacchus Vascular, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,929,633
App. No.
10/278,735
Granted
Aug 16, 2005
Kind
B2
Abstract

Clot disruption and dissolution are achieved using a catheter having the ability to infuse a thrombolytic agent, agitate the clot and agent, and aspirate broken-up clot from the blood vessel. A flow resistor in the catheter provides for infusion and/or aspiration to be concentrated primarily at a clot treatment area in a blood vessel while also providing optional infusion and/or aspiration distal to the treatment area. In some embodiments, infusion, aspiration and guidewire passage occur through a common lumen. The thrombolytic agent, such as tPA, streptokinase, or urokinase, is directly released into the clot at the point where the agitator is engaging the clot. In this way, the thrombolytic activity of the agent is enhanced and the dissolution of the clot is improved.

Claims (21)

1. A method for disrupting clot over a luminal length of a blood vessel, said method comprising:

positioning a catheter body within the luminal length of the blood vessel;

infusing a thrombolytic agent through a lumen of the catheter body into the luminal length of the blood vessel;

expanding an agitator within the catheter body to eccentrically deform a portion of the body; and

rotating the agitator to sweep the catheter body within the luminal length of the blood vessel to agitate the thrombolytic agent within the clot.

2. A method as in claim 1 , wherein positioning the catheter body includes passing the catheter body over a guidewire.

3. A method as in claim 1 , wherein the catheter is rotated at a frequency of 1-20,000 Hertz.

4. A method as in claim 1 , wherein the agitator is resilient and radially self-expanding so that it is constrained by the blood vessel as it is rotated.

5. A method as in claim 4 , wherein the agitator has a non-linear geometry when expanded.

6. A method as in claim 1 , wherein the luminal length is at least 3 cm.

7. A method as in claim 1 , wherein the blood vessel is a vein.

8. A method as in claim 7 , wherein the vein is selected from the group consisting of vena cava, iliac vein, femoral vein, popliteal vein, common iliac vein, external iliac vein, brachial vein, and subclavian vein.

9. A method as in claim 1 , wherein the blood vessel is an artery.

10. A method as in claim 9 , wherein the artery is selected from the group consisting of the internal iliac artery, external iliac artery, popliteal artery, coronary arteries, superficial femoral artery, and the brachial artery.

11. A method as in claim 1 , further comprising isolating at least one end of the luminal length of the blood vessel.

12. A method as in claim 11 , further comprising isolating both a proximal end and a distal end of the luminal length.

13. A method as in claim 11 , wherein isolating comprises inflating at least one occlusion balloon.

14. A method as in claim 11 , wherein isolating at least a distal end is performed prior to infusing the agent.

15. A method as in claim 14 , wherein isolating at least one distal end is maintained until after agitating has stopped.

16. A method as in claim 1 , further comprising aspirating disrupted clot material from along the luminal length of the blood vessel.

17. A method as in claim 16 , wherein aspirating disrupted clot and infusing the agent are performed through a common lumen in the catheter body.

Assignments (7)
CHANGE OF NAME Recorded Jan 9, 2013
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029595/0101 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2010
From: SHERWOOD MEDICAL COMPANY I
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 024651/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2010
From: VALLEYLAB HOLDING CORPORATION
To: TYCO HEALTHCARE GROUP LP
Reel/Frame 024651/0256 →
ASSIGNMENT OF FORTY NINE PERCENT (49%) OF ASSIGNOR'S ENTIRE RIGHT, TITLE, AND INTEREST Recorded Jul 8, 2010
From: BACCHUS VASCULAR, LLC
To: VALLEYLAB HOLDING CORPORATION
Reel/Frame 024651/0309 →
ASSIGNMENT OF FIFTY ONE PERCENT (51%) OF ASSIGNOR'S ENTIRE RIGHT, TITLE, INTEREST, AND THE GOODWILL Recorded Jul 8, 2010
From: BACCHUS VASCULAR, LLC
To: SHERWOOD MEDICAL COMPANY I
Reel/Frame 024651/0280 →
MERGER Recorded Jul 7, 2010
From: BACCHUS VASCULAR, INC.
To: BACCHUS VASCULAR, LLC
Reel/Frame 024640/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 31, 2003
From: EVANS, MICHAEL A.; DEMARAIS, DENISE; DE CICCO, DINO; NING, KELVIN; KHAIRKHAHAN, ALEXANDER; STRANG, TYLER JON; CIMBALO, JODY MARIA; LEEFLANG, STEPHEN
To: BACCHUS VASCULAR INC.
Reel/Frame 013917/0512 →
Continuity (4)
Continuation In Part 1014200500 · May 8, 2002
Continuation In Part PCTUS010240600 · Jan 24, 2001
Continuation In Part 0949140100 · Jan 25, 2000
Related Publication 20030139751A1 · Jul 24, 2003